{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:16Z","timestamp":1792090036647,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11213-9","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:49:50Z","timestamp":1789501790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study"],"prefix":"10.1007","volume":"34","author":[{"given":"Danyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"1","key":"11213_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-025-01673-7","volume":"18","author":"L Fu","year":"2025","unstructured":"Fu L, Zhou X, Zhang X et al (2025) Circulating tumor DNA in lymphoma: technologies and applications. J Hematol Oncol 18(1):29. https:\/\/doi.org\/10.1186\/s13045-025-01673-7","journal-title":"J Hematol Oncol"},{"issue":"3","key":"11213_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"11213_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2329130","volume":"56","author":"A Shi","year":"2024","unstructured":"Shi A, Yun F, Shi L et al (2024) Research progress on the mechanism of common inflammatory pathways in the pathogenesis and development of lymphoma. Ann Med 56(1):2329130. https:\/\/doi.org\/10.1080\/07853890.2024.2329130","journal-title":"Ann Med"},{"key":"11213_CR4","doi-asserted-by":"publisher","unstructured":"Zheng R, Chen R, Han B et al (2024) Analysis of cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi 46(3):221\u2013231. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20240119-00035","DOI":"10.3760\/cma.j.cn112152-20240119-00035"},{"issue":"10","key":"11213_CR5","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/10428194.2024.2352086","volume":"65","author":"M Di","year":"2024","unstructured":"Di M, Su CT, Cowan AJ et al (2024) Mitigating time toxicity in lymphoma and multiple myeloma. Leuk Lymphoma 65(10):1418\u20131429. https:\/\/doi.org\/10.1080\/10428194.2024.2352086","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"11213_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2024.100610","volume":"11","author":"C Nwozichi","year":"2024","unstructured":"Nwozichi C, Omolabake S, Ojewale MO et al (2024) Time toxicity in cancer care: a concept analysis using Walker and Avant\u2019s method. Asia Pac J Oncol Nurs 11(12):100610. https:\/\/doi.org\/10.1016\/j.apjon.2024.100610","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"7","key":"11213_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1701\/4062.40458","volume":"114","author":"M Rossi","year":"2023","unstructured":"Rossi M (2023) La tossicit\u00e0 temporale nel paziente oncologico [The time toxicity in cancer patient]. Recenti Prog Med 114(7):407\u2013409. https:\/\/doi.org\/10.1701\/4062.40458","journal-title":"Recenti Prog Med"},{"issue":"3","key":"11213_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-024-07379-7","volume":"207","author":"SY Atre","year":"2024","unstructured":"Atre SY, Soulos PR, Kuderer NM et al (2024) Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Res Treat 207(3):541\u2013550. https:\/\/doi.org\/10.1007\/s10549-024-07379-7","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"11213_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235677","volume":"15","author":"NY Agrawal","year":"2023","unstructured":"Agrawal NY, Thawani R, Edmondson CP et al (2023) Estimating the time toxicity of contemporary systemic treatment regimens for advanced esophageal and gastric cancers. Cancers (Basel) 15(23):5677. https:\/\/doi.org\/10.3390\/cancers15235677","journal-title":"Cancers (Basel)"},{"issue":"7","key":"11213_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.clml.2024.02.013","volume":"24","author":"R Banerjee","year":"2024","unstructured":"Banerjee R, Cowan AJ, Ortega M et al (2024) Financial toxicity, time toxicity, and quality of life in multiple myeloma. Clin Lymphoma Myeloma Leuk 24(7):446-454.e3. https:\/\/doi.org\/10.1016\/j.clml.2024.02.013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"11213_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/OP.23.00811","volume":"20","author":"SM Durbin","year":"2024","unstructured":"Durbin SM, Lundquist DM, Pelletier A et al (2024) Time toxicity experienced by early-phase cancer clinical trial participants. JCO Oncol Pract 20(9):1252\u20131262. https:\/\/doi.org\/10.1200\/OP.23.00811","journal-title":"JCO Oncol Pract"},{"issue":"12","key":"11213_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59122121","volume":"59","author":"L Cavanna","year":"2023","unstructured":"Cavanna L, Citterio C, Mordenti P et al (2023) Cancer treatment closer to the patient reduces travel burden, time toxicity, and improves patient satisfaction: results of 546 consecutive patients in a Northern Italian district. Medicina (Kaunas) 59(12):2121. https:\/\/doi.org\/10.3390\/medicina59122121","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"11213_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50211","volume":"6","author":"KB Patel","year":"2023","unstructured":"Patel KB, Turner K, Alishahi Tabriz A et al (2023) Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw Open 6(1):e2250211. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50211","journal-title":"JAMA Netw Open"},{"issue":"9","key":"11213_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/oncolo\/oyad128","volume":"28","author":"A Gupta","year":"2023","unstructured":"Gupta A, Hay AE, Crump M et al (2023) Contact days associated with cancer treatments in the CCTG LY.12 trial. Oncologist 28(9):799\u2013803. https:\/\/doi.org\/10.1093\/oncolo\/oyad128","journal-title":"Oncologist"},{"issue":"4","key":"11213_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09335-7","volume":"33","author":"H Araie","year":"2025","unstructured":"Araie H, Seki T, Okada A et al (2025) Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan. Support Care Cancer 33(4):293. https:\/\/doi.org\/10.1007\/s00520-025-09335-7","journal-title":"Support Care Cancer"},{"issue":"7","key":"11213_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyag202","volume":"31","author":"A Major","year":"2026","unstructured":"Major A, Ma E, Masaquel A et al (2026) Patient-reported time toxicity with bispecific antibody therapies in relapsed\/refractory follicular lymphoma and diffuse large B-cell lymphoma. Oncologist 31(7):oyag202. https:\/\/doi.org\/10.1093\/oncolo\/oyag202","journal-title":"Oncologist"},{"key":"11213_CR17","doi-asserted-by":"publisher","unstructured":"Major A, Ma E, Werner S et al (2025) Time toxicity in the era of bispecific antibody treatment in relapsed\/refractory non-Hodgkin lymphoma: concept elicitation with hematologists and patient perspectives. Hematol Oncol 43(S3):e874_70096. https:\/\/doi.org\/10.1002\/hon.70096_874","DOI":"10.1002\/hon.70096_874"},{"issue":"11","key":"11213_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.47649","volume":"7","author":"A Gupta","year":"2024","unstructured":"Gupta A, Johnson WV, Henderson NL et al (2024) Patient, caregiver, and clinician perspectives on the time burdens of cancer care. JAMA Netw Open 7(11):e2447649. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.47649","journal-title":"JAMA Netw Open"},{"issue":"7","key":"11213_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09621-4","volume":"33","author":"SX Stevens","year":"2025","unstructured":"Stevens SX, El-Katateny E, De Abreu Louren\u00e7o R et al (2025) \u201cThe cancer is my life\u201d: patient and caregiver perceptions of the time toxicity of palliative systemic cancer treatments for advanced gastrointestinal cancers. Support Care Cancer 33(7):564. https:\/\/doi.org\/10.1007\/s00520-025-09621-4","journal-title":"Support Care Cancer"},{"issue":"10","key":"11213_CR20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00520-025-09904-w","volume":"33","author":"J Jing","year":"2025","unstructured":"Jing J, Li M, Rui Y et al (2025) The weight of time: experience of time toxicity among advanced cancer patients and their family caregivers\u2014a qualitative study. Support Care Cancer 33(10):862. https:\/\/doi.org\/10.1007\/s00520-025-09904-w","journal-title":"Support Care Cancer"},{"issue":"1","key":"11213_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1435-5597.1970.tb01464.x","volume":"24","author":"T H\u00e4gerstrand","year":"1970","unstructured":"H\u00e4gerstrand T (1970) What about people in regional science? Pap Reg Sci 24(1):7\u201321. https:\/\/doi.org\/10.1111\/j.1435-5597.1970.tb01464.x","journal-title":"Pap Reg Sci"},{"issue":"6","key":"11213_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"11213_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC (2017) Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res 27(4):591\u2013608. https:\/\/doi.org\/10.1177\/1049732316665344","journal-title":"Qual Health Res"},{"issue":"9","key":"11213_CR24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15(9):1277\u20131288. https:\/\/doi.org\/10.1177\/1049732305276687","journal-title":"Qual Health Res"},{"issue":"6","key":"11213_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf165","volume":"30","author":"A Gupta","year":"2025","unstructured":"Gupta A, Thomas T, Hay AE et al (2025) The association of health care contact days with economic measures in the CCTG LY.12 trial. Oncologist 30(6):oyaf165. https:\/\/doi.org\/10.1093\/oncolo\/oyaf165","journal-title":"Oncologist"},{"issue":"11","key":"11213_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00520-025-09954-0","volume":"33","author":"WV Johnson","year":"2025","unstructured":"Johnson WV, Valisekka SS, Ogunleye OO et al (2025) Patient-, care partner-, and clinician-proposed solutions to address the time toxicity of cancer care. Support Care Cancer 33(11):965. https:\/\/doi.org\/10.1007\/s00520-025-09954-0","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11213-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:38Z","timestamp":1792086518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11213-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11213"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11213-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"976"}}